Centro de Documentação da PJ
Monografia

2809019.D.89
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION
Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs / European Monitoring Centre for Drugs and Drug Addiction, EMCDDA.- Luxembourg : Office for Official Publications of the European Communities, 2002.- 92 p. ; 21 cm
ISBN 92-9168-122-9

PREVENÇÃO DA TOXICODEPENDÊNCIA, RELATÓRIO, DROGA SINTÉTICA, COOPERAÇÃO INTERNACIONAL, OEDT, EMCDDA

Foreword. Abbreviations. Introduction. report on the risk assessment of GBH in the framework of the joint action on new synthetic drugs. Europol-EMCDDA progress report on GHB in accordance with Article 3 of the joint action of 16 June 1997 concerning the information exchange, risk assessment and the control of new synthetic drugs. Use of GHB as a medicinal product (EMEA). Review of the pharmacotoxicological data on gamma-hydroxybutyric acid (GHB). Sociological and criminological (Europol) evidence on the risks of GHB. Public health risks of GHB - epidemiological evidence. References. Participants in the risk-assessment process.